<DOC>
	<DOCNO>NCT01187810</DOCNO>
	<brief_summary>The purposee study determine safety dose Fenretinide give continuously 5 day , every 3 week , pediatric patient recurrent and/or resistant acute lymphoblastic leukemia ( ALL ) , acute myelogenous leukemia ( AML ) , non-Hodgkin 's lymphoma ( NHL ) .</brief_summary>
	<brief_title>Fenretinide Children With Recurrent/Resistant ALL , AML , NHL</brief_title>
	<detailed_description>Fenretinide cytotoxic retinoid activity variety cell line vitro dose-related manner . The exact mechanism fenretinide cytotoxicity leukemia lymphoma cell line know , may include de novo ceramide synthesis ceramides generation reactive oxygen specie . The malignancy-specific nature fenretinide-induced ceramides suggest combination drug ceramide modulate agent may favorable therapeutic index . In study , primary aim define maximum tolerate dose , toxicity profile , pharmacokinetics IV fenretinide give continuously pediatric patient ALL , AML , NHL . The drug administer via central venous percutaneous indwell central catheter inpatient hospital setting .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Fenretinide</mesh_term>
	<criteria>Diagnosed relapsed refractory ALL , AML , NHL Must two therapeutic attempt treating/curing disease Must fully recoved acute toxic effect prior therapy Karnofsky great 50 % old 10 year age Lansky great 50 % young 10 year . Grade 2 Pruritus Rash ( form ) Grade 3 Dry Skin refractory topical medical management Cardiac Fractional Shortening &lt; 27 % echocardiogram Left Ventricular Ejection Fraction &lt; 45 % echocardiogram Known allergy egg product soy bean oil Renal , Liver , Pancreatic function : serum creatinine &gt; 1.5X ULN direct bilirubin &gt; 1.5X ULN ALT AST &gt; 2.5X ULN Serum trigylcerides &gt; 2.5X ULN age Lipase &gt; 1.5X ULN age History pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>leukemia , lymphoma</keyword>
</DOC>